5 ms·
https://newsroom.uw.edu/news/glasses-stop-myopia-are-successful-multi-site-trial https://newsroom.uw.edu/news/glasses-stop-myopia-are-success... Their big brea
by helloworld 4y ago
https://newsroom.uw.edu/news/glasses-stop-myopia-are-successful-multi-site-trial https://newsroom.uw.edu/news/glasses-stop-myopia-are-success...
Their big breakthrough in understanding myopia occurred in 2008 when they studied a particular group of people who had a genetic form of myopia that’s very severe. They discovered a gene mutation that was causing the myopia.
“It turns out it was a mutation in the cone photoreceptors,” said Jay Neitz. “We then realized that it’s really just the way that the images are being encoded on the retina.”
What’s supposed to happen as your eye grows, is that things should begin to go out of focus in the periphery of your vision. That’s a signal for the eyes to stop growing.
But as long as things are still clear in the periphery, the eyes think this person must still be farsighted, because in the natural world things in the periphery are far away.
Neitz said his team was able to design a lens to make central vision clear and in focus, and give the peripheal vision much lower contrast.
“It recreates what is supposed to be going on with our eyes before we started putting all of these things in front of our face like computer screens and tablets,” he said.
- xeromal 4y agoI love how they discovered this!
- forum_ghost 4y agoFailed in clinical trials? Never heard about this until now.
- helloworld 4y agoUpdate Jan. 20, 2021: The North America myopia trial is nearing the end of its second year and it is closed to enrollment. Based on the one-year data, the eyeglasses have regulatory approval to be sold as medical devices in Europe and Canada. They are currently being sold in Canada under the brand name "Kikko." Researchers anticipate regulatory approval in the United States in about a year that will be based on the two-year results. People can go to the Kikko website https://kikkovision.com/ https://kikkovision.com/ and sign up to receive updates about U.S. availability. Once they are approved in the U.S., people will be able to buy the glasses from their optometrist or ophthalmologist.
- amai 4y ago„The CYPRESS clinical study3 enrolled, randomized, and dispensed the lenses to 256 eligible children across 14 clinical trial sites in the United States and Canada. At the time of enrollment, subjects were six to 10 years old having myopia between -0.75 D and -4.50 D. After two years of wear, 85% of children wearing the innovative spectacle lenses showed less than one diopter of myopia progression.4 Moreover, the study also showed that 41% of the children wearing spectacle lenses with Diffusion Optics Technology™ showed no clinically meaningful progression in refractive error after two years versus only 17% in the control group.5“ See https://www.coopervisionsec.eu/news-two-year-clinical-trial-results https://www.coopervisionsec.eu/news-two-year-clinical-trial-...
- amai 4y agoSee also https://reviewofmm.com/the-latest-science-on-myopia-control-spectacles/ https://reviewofmm.com/the-latest-science-on-myopia-control-...